Biotech Stocks Look Ready To Rebound

... a number of companies have been very aggressively buying," Timothy Chiang, an analyst at CRT Capital Group LLC in Stamford, Connecticut, said in a phone interview. "It's tougher to stay in the pharma business if you're so heavily reliant on just a ...

http://ift.tt/1knTuQx